Seres Therapeutics Inc Earnings

The next earnings date for Seres Therapeutics Inc has not yet been scheduled.

Analyst Estimates of Seres Therapeutics Inc Earnings

No Results.

Report Date	Estimated Earnings Per Share
No Results.

What is an Earnings Date

An earnings date is typically considered to be the date that a company publicly announces its earnings. Many companies in the US stock market do earnings announcements once per quarter.

Earnings announcements are typically accompanied by commentary from the company that explains the earnings performance and speaks to future earnings prospects.

Earnings announcements can cause a company’s stock price to change abruptly, so earnings dates are closely monitored by some investors.

Seres Therapeutics Inc Earnings: Historical

Report Date	Before/After Market	Earnings Per Share	Surprise %
08/06/2025	---	$-2.27	-2,422.22%
05/06/2025	Before Market	$-2.24	-213.57%
03/03/2025	Before Market	$-0.11	44.81%
10/31/2024	Before Market	$-0.33	-16,400.00%
08/13/2024	Before Market	$-0.22	18.52%
05/08/2024	Before Market	$-0.27	20.59%
03/05/2024	Before Market	$-0.32	36.00%
11/02/2023	Before Market	$-0.37	26.00%
08/08/2023	Before Market	$0.36	-32.08%
05/09/2023	Before Market	$-0.57	-3.64%
03/07/2023	Before Market	$-0.54	-17.39%
11/02/2022	Before Market	$-0.49	-4.26%
08/03/2022	Before Market	$-0.70	-16.67%
05/04/2022	Before Market	$-0.61	-17.31%
03/01/2022	Before Market	$-0.52	-18.18%
11/10/2021	Before Market	$0.72	256.52%
08/03/2021	Before Market	$-0.53	-43.24%
05/04/2021	Before Market	$-0.39	-25.81%
03/02/2021	Before Market	$-0.23	17.86%
11/09/2020	Before Market	$-0.36	-38.46%
07/28/2020	Before Market	$-0.28	-7.69%
05/07/2020	Before Market	$-0.28	0.00%
03/02/2020	Before Market	$-0.25	10.71%
11/05/2019	Before Market	$-0.23	28.13%
08/06/2019	Before Market	$-0.24	50.00%
05/02/2019	Before Market	$-0.59	-47.50%
03/06/2019	Before Market	$-0.52	-4.00%
11/08/2018	Before Market	$-0.54	-3.85%
08/02/2018	Before Market	$-0.68	-7.94%
05/09/2018	Before Market	$-0.69	9.21%
03/08/2018	Before Market	$-0.72	4.00%
11/08/2017	Before Market	$-0.17	58.54%
08/03/2017	Before Market	$-0.69	-7.81%
05/04/2017	Before Market	$-0.63	4.55%
03/16/2017	Before Market	$-0.63	12.50%
11/10/2016	Before Market	$-0.46	8.00%
08/11/2016	Before Market	$-0.70	-52.17%
05/16/2016	Before Market	$-0.50	-4.17%
02/25/2016	Before Market	$-0.41	0.00%
11/10/2015	Before Market	$-0.38	-18.75%
08/06/2015	After Market	$-1.45	-383.33%

More About Seres Therapeutics Inc

Website

https://www.serestherapeutics.com

Country

USA

Full Time Employees

103

Seres Therapeutics, Inc., a clinical-stage company, focuses on developing biotherapeutics for serious diseases. The company develops SER-155, an investigational oral live biotherapeutic to decolonize gastrointestinal pathogens, enhance epithelial barrier integrity, and regulate immune response to prevent bacterial bloodstream infections, as well as other pathogen-associated negative clinical outcomes in patients undergoing allogeneic hematopoietic stem cell transplantation. Its other pipeline programs include SER-147, a live biotherapeutic composition to prevent bacterial bloodstream and spontaneous bacterial peritonitis infections in patients with metabolic disease, including chronic liver disease; and SER-287 and SER-301, which are in clinical trials for the treatment of mild-to-moderate ulcerative colitis. The company was formerly known as Seres Health, Inc. and changed its name to Seres Therapeutics, Inc. in May 2015. Seres Therapeutics, Inc. was incorporated in 2010 and is headquartered in Cambridge, Massachusetts.

“Seres Therapeutics Inc Earnings” Can Refer to the Seres Therapeutics Inc Earnings Date

Some people say “Seres Therapeutics Inc earnings” as a shortform way to refer to the earnings date.

For example, someone might say, “I plan to hold my Seres Therapeutics Inc position through earnings.” That typically means the person is going to hold their position through the upcoming earnings date.

Owning Seres Therapeutics Inc Stock on the Earnings Date

If you own Seres Therapeutics Inc stock (MCRB) on the earnings date, then you will be exposed to the potential price volatility that often accompanies earnings announcements.

A company’s earnings typically have a big impact on its stock price, which explains why the stock price for Seres Therapeutics Inc might exhibit major fluctuations on the day of the earnings announcement. The price fluctuations can go in either direction (up or down), representing a larger potential investment risk and reward than many other days of the year.

There is often a big audience of investors involved with trading Seres Therapeutics Inc shares of stock on its earnings day. This means there is typically more trading volume, liquidity, and price volatility on the day earnings are announced.

These features are attractive to some types of active traders who are looking for stocks that exhibit large price movements and substantial volume.

Learning More Seres Therapeutics Inc Earnings

You can contact us any time if you would like to ask questions about Seres Therapeutics Inc earnings or anything else related to the stock market.